175 related articles for article (PubMed ID: 6721466)
1. Effect of inoculum, pH, and medium on the activity of ciprofloxacin against anaerobic bacteria.
Borobio MV; Perea EJ
Antimicrob Agents Chemother; 1984 Mar; 25(3):342-3. PubMed ID: 6721466
[TBL] [Abstract][Full Text] [Related]
2. Is ciprofloxacin active against clinically important anaerobes?
Watt B; Brown FV
J Antimicrob Chemother; 1986 May; 17(5):605-13. PubMed ID: 2941400
[TBL] [Abstract][Full Text] [Related]
3. Comparison of susceptibilities of anaerobic bacteria determined by agar dilution and by a microbroth method.
Baron EJ; Bruckner DA
Rev Infect Dis; 1984; 6 Suppl 1():S249-53. PubMed ID: 6718938
[TBL] [Abstract][Full Text] [Related]
4. [In vitro activity of an ofloxacin-metronidazole combination against anaerobic bacteria. Kinetics of the action of metronidazole against Bacteroides fragilis].
Dubreuil L; Devos J; Beerens H; Romond C
Pathol Biol (Paris); 1988 May; 36(5):488-92. PubMed ID: 3043345
[TBL] [Abstract][Full Text] [Related]
5. Effect of inoculum size and medium on activity of seven antimicrobial agents against Bacteroides fragilis strains.
Wexler HM; Reeves D; Finegold SM
Clin Ther; 1989; 11(6):828-33. PubMed ID: 2611824
[TBL] [Abstract][Full Text] [Related]
6. Comparative in vitro activities of ciprofloxacin, enoxacin, norfloxacin, ofloxacin and pefloxacin against Bacteroides fragilis and Clostridium difficile.
Edlund C; Nord CE
Scand J Infect Dis; 1986; 18(2):149-51. PubMed ID: 2939556
[TBL] [Abstract][Full Text] [Related]
7. Comparison of activities of trovafloxacin (CP-99,219) and five other agents against 585 anaerobes with use of three media.
Hecht DW; Osmolski JR
Clin Infect Dis; 1996 Dec; 23 Suppl 1():S44-50. PubMed ID: 8953106
[TBL] [Abstract][Full Text] [Related]
8. Antimicrobial spectrum of Win 49375.
Jacobus NV; Tally FP; Barza M
Antimicrob Agents Chemother; 1984 Jul; 26(1):104-7. PubMed ID: 6476813
[TBL] [Abstract][Full Text] [Related]
9. In vitro susceptibility of anaerobic bacteria to ciprofloxacin (Bay o 9867).
Prabhala RH; Rao B; Marshall R; Bansal MB; Thadepalli H
Antimicrob Agents Chemother; 1984 Nov; 26(5):785-6. PubMed ID: 6517561
[TBL] [Abstract][Full Text] [Related]
10. Evaluation of the in vitro activity of levornidazole, its metabolites and comparators against clinical anaerobic bacteria.
Hu J; Zhang J; Wu S; Zhu D; Huang H; Chen Y; Yang Y; Zhang Y
Int J Antimicrob Agents; 2014 Dec; 44(6):514-9. PubMed ID: 25301712
[TBL] [Abstract][Full Text] [Related]
11. Comparative in vitro antimicrobial susceptibilities of a special panel of 74 Bacteroides fragilis group isolates in Wilkins-Chalgren agar with and without sheep blood.
Gill CJ; Shungu DL; Ponticas S
Antimicrob Agents Chemother; 1989 Mar; 33(3):394-5. PubMed ID: 2729933
[TBL] [Abstract][Full Text] [Related]
12. Comparative anti-anaerobic activity of Men 10700, a penem antibiotic.
Hamilton-Miller JM; Shah S
Int J Antimicrob Agents; 1998 Nov; 10(4):321-4. PubMed ID: 9916909
[TBL] [Abstract][Full Text] [Related]
13. Influence of environmental factors on the in vitro efficacy of ciprofloxacin against anaerobic bacteria.
Thadepalli H; Bansal MB; Marshall R; Prabhala RH
Chemotherapy; 1989; 35(3):153-9. PubMed ID: 2766855
[TBL] [Abstract][Full Text] [Related]
14. Susceptibility of anaerobic bacteria to Sch 34343 and other antibiotics.
Glupczynski Y; Gordts B; van der Linden MP; Labbé M; Yourassowsky E; Butzler JP
J Antimicrob Chemother; 1985 Jun; 15 Suppl C():193-8. PubMed ID: 4030548
[TBL] [Abstract][Full Text] [Related]
15. [In vitro activity of a combination of amoxicillin-clavulanic acid on anaerobic bacteria].
Sedallian A; Roudon T
Pathol Biol (Paris); 1988 Jun; 36(5 Pt 2):678-81. PubMed ID: 3054746
[TBL] [Abstract][Full Text] [Related]
16. In vitro activity of flomoxef compared to moxalactam, cefoxitin, cefotaxime, and clindamycin against anaerobes.
Werner H; Heizmann W; Luft G
Arzneimittelforschung; 1988 Nov; 38(11):1553-6. PubMed ID: 3214438
[TBL] [Abstract][Full Text] [Related]
17. The comparative activity of twelve 4-quinolone antimicrobials against gram-positive and gram-negative anaerobes.
Robbins MJ; O'Hare MD; Felmingham D; Ridgway GL; Grüneberg RN
Drugs Exp Clin Res; 1985; 11(7):431-4. PubMed ID: 3836865
[TBL] [Abstract][Full Text] [Related]
18. Comparative activity of SCH 34343 against anaerobic bacteria.
Sutter VL; Wexler H; Finegold SM
Diagn Microbiol Infect Dis; 1986 Apr; 4(4):341-4. PubMed ID: 3698546
[TBL] [Abstract][Full Text] [Related]
19. Effect of medium, pH, and inoculum size on activity of ceftizoxime and Sch-34343 against anaerobic bacteria.
Borobio MV; Pascual A; Dominguez MC; Perea EJ
Antimicrob Agents Chemother; 1986 Oct; 30(4):626-7. PubMed ID: 3466569
[TBL] [Abstract][Full Text] [Related]
20. Susceptibility of anaerobic bacteria to five antimicrobial agents and demonstration of resistance of Bacteroides fragilis to clindamycin.
Sofianou D; Douboyas J; Papapanagiotou J; Paradelis AG
Methods Find Exp Clin Pharmacol; 1982; 4(3):173-7. PubMed ID: 7121128
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
